SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (75)1/13/1999 4:55:00 PM
From: Biomaven  Read Replies (1) of 3158
 
nigel,

Good suggestion - I added it to Prey. Don't know how Amgen feels about gobbling its partners, but I think both GLFD and NPSP would be smart acquisitions for it. (Of course this depends on how these partnered programs are doing, which AMGN itself knows better than anyone else.) If NIL is successful, AMGN will end up paying more in milestones than just buying GLFD outright.

GLFD also has enough cash to do a little gobbling of its own. Something like GLFD/SIBI might make sense - this is something that Rick would have a better feel than me for. Of course I don't know if the market would reward this sort of merger, but it should. The specter of AXPH still hangs heavy over any "sideways" mergers, however.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News